+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bifidobacterium Longum Subsp. Infantis M-63 Market - Global Forecast 2026-2032- Product Image
Bifidobacterium Longum Subsp. Infantis M-63 Market - Global Forecast 2026-2032- Product Image
Sale

Bifidobacterium Longum Subsp. Infantis M-63 Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082211
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bifidobacterium Longum Subsp. Infantis M-63 Market is projected to reach USD 585.64 Million in 2026. It is expected to continue growing at a CAGR of 9.25%, reaching USD 1.00 Billion by 2032.

Bifidobacterium longum subsp. infantis M-63: Executive Overview

Bifidobacterium longum subsp. infantis M-63 is a strain-specific infant gut microbiota ingredient associated with research on early-life microbial development, human milk oligosaccharide utilization, and gastrointestinal health. Its relevance is shaped by clinical evidence, formulation stability, regulatory requirements, and responsible communication of benefits. Interpretation should distinguish evidence for the specific M-63 strain from findings on the broader Bifidobacterium infantis category.

Evidence, Formulation, and Regulatory Shifts Reshaping the Category

The landscape is moving toward strain-level substantiation, better characterization of infant microbiome development, and tighter control of quality and safety claims. Product development increasingly depends on viable-cell stability through processing and storage, compatibility with infant nutrition formats, and validated analytical methods. Regulatory expectations also differ by jurisdiction, making documentation of identity, manufacturing controls, clinical relevance, and intended use essential.

Artificial Intelligence Strengthens Strain Research and Quality Operations

Artificial intelligence can support literature screening, microbiome-data analysis, formulation optimization, anomaly detection, and traceability across production records. Its value is cumulative when linked with validated laboratory methods, clinical datasets, and human review. AI-generated associations should not be treated as clinical evidence without prospective validation, transparent model governance, privacy safeguards, and confirmation that findings apply specifically to M-63 rather than to unrelated strains.

Regional Insights Across Six Distinct Regulatory and Adoption Contexts

North America emphasizes evidence quality, product compliance, and differentiated infant-health positioning, while Latin America presents varied regulatory systems and distribution conditions that increase the importance of local partners and clear labeling. Europe places strong weight on precaution, authorized claims, infant-nutrition standards, and data quality. The Middle East combines sophisticated healthcare channels with country-specific registration requirements, and Africa requires attention to affordability, supply continuity, and locally relevant maternal and infant-health priorities. Asia-Pacific remains especially important for research, infant nutrition innovation, and diverse regulatory pathways, with implementation requiring market-specific validation rather than a uniform regional approach.

Group Insights: Policy Blocs and Economic Networks Shape Execution

ASEAN markets require coordinated but not identical approaches because national rules, import procedures, and healthcare systems differ. BRICS economies combine significant scientific and manufacturing capabilities with varied evidence and registration expectations. The European Union benefits from a harmonized policy framework but retains demanding standards for safety, claims, and infant products. G7 markets generally prioritize robust clinical documentation, quality systems, and post-market oversight. GCC markets call for careful alignment with national registration, halal considerations where applicable, and specialized healthcare distribution. NATO countries are not a single regulatory market, yet their shared security and resilience priorities can heighten attention to pharmaceutical-grade supply continuity and trusted sourcing.

Country Insights: Tailoring Development and Compliance by Market

Australia and Canada generally reward strong evidence packages and transparent product communication. Brazil and Mexico require careful navigation of national regulatory procedures and local labeling expectations. China and India offer substantial research and manufacturing opportunities but demand market-specific registration, quality, and clinical strategies. Japan and South Korea place strong emphasis on product quality, scientific substantiation, and consumer trust. France, Germany, Italy, and Spain operate within the European framework while retaining national differences in healthcare practice, reimbursement, and professional adoption. The United Kingdom maintains a distinct post-EU regulatory environment, and the United States requires disciplined alignment between intended use, product category, claims, and supporting evidence. Russia presents additional considerations involving local regulatory processes, logistics, and supply-chain risk.

Action Priorities for Leaders Developing M-63 Applications

Leaders should first define a narrow, evidence-aligned intended use and maintain a clear distinction between strain-specific findings and broader probiotic research. They should establish identity, purity, potency, stability, contamination-control, and batch-release systems before scaling distribution. Clinical and observational programs should use appropriate infant endpoints, transparent protocols, and independent oversight. Regulatory plans should be mapped separately by jurisdiction, while supply strategies should include qualified raw-material sources, cold-chain or stability controls where needed, and contingency manufacturing. Finally, communications should be reviewed by scientific, medical, legal, and ethics teams to avoid overstating benefits or implying that supplementation replaces breastfeeding or clinical care.

Research Methodology for a Strain-Specific Executive Assessment

This assessment uses the supplied market topic as a scope definition and applies a structured review framework covering strain biology, infant microbiome research, formulation and manufacturing considerations, regulatory themes, regional operating conditions, and responsible commercialization. Findings are framed qualitatively and avoid unsupported estimates, shares, forecasts, or company-specific claims. Because the reference supplied no study set, numerical market data, or jurisdiction-specific dossiers, conclusions should be validated against current peer-reviewed literature, official regulatory guidance, clinical-trial records, and product-quality documentation before operational decisions are made.

Conclusion: Evidence Discipline Should Guide M-63 Development

M-63 sits at the intersection of strain-specific microbiology, infant nutrition, clinical evidence, and highly sensitive regulatory communication. The strongest path forward is disciplined: verify the science, control product quality, tailor compliance by country, and use AI only within validated governance frameworks. Organizations that connect rigorous evidence with resilient manufacturing and responsible communication will be better positioned to evaluate appropriate applications while protecting infant safety and public trust.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Application
7.1. Introduction
7.2. Animal Feed
7.2.1. Aquaculture Feed
7.2.2. Livestock Feed
7.2.3. Pet Food
7.3. Dietary Supplements
7.3.1. Adult Supplements
7.3.2. Elderly Supplements
7.3.3. Infant Supplements
7.4. Functional Foods
7.4.1. Beverages
7.4.2. Dairy Products
7.4.3. Snack Bars
7.5. Infant Formula
7.5.1. Cow Milk-Based
7.5.2. Hypoallergenic
7.5.3. Soy-Based
7.6. Pharmaceuticals
7.6.1. Adjunctive Therapies
7.6.2. Probiotic Therapeutics
8. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Form
8.1. Introduction
8.2. Capsule
8.2.1. Enteric-Coated
8.2.2. Non-Enteric
8.3. Liquid
8.4. Powder
8.5. Tablet
9. Bifidobacterium Longum Subsp. Infantis M-63 Market, by End User
9.1. Introduction
9.2. Adults
9.3. Children
9.4. Elderly
9.5. Infants
10. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Distribution Channel
10.1. Introduction
10.2. Online
10.3. Offline
11. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. BioGaia AB
15.2. Chr. Hansen A/S
15.3. Danone S.A.
15.4. DuPont de Nemours, Inc.
15.5. Evolve Biosystems
15.6. Fengchen Group Co., Ltd.
15.7. Fido Pharma Pvt. Ltd.
15.8. Kerry Group plc
15.9. Lallemand Inc.
15.10. Mead Johnson Nutrition
15.11. Molkem
15.12. Morinaga Milk Industry Co., Ltd.
15.13. Nestlé S.A.
15.14. Probi AB
15.15. Yakult Honsha Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Bifidobacterium Longum Subsp. Infantis M-63 Market, Years Considered for the Study
FIGURE 2. Global Bifidobacterium Longum Subsp. Infantis M-63 Market, Research Design
FIGURE 3. Global Bifidobacterium Longum Subsp. Infantis M-63 Market, Research Framework
FIGURE 4. Global Bifidobacterium Longum Subsp. Infantis M-63 Market, Data Triangulation
FIGURE 5. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2025 vs 2032 (%)
FIGURE 7. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2025 vs 2032 (%)
FIGURE 9. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Segmentation & Coverage
TABLE 2. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, 2017-2032 (USD Million)
TABLE 3. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 4. Global Animal Feed Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Animal Feed Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Animal Feed Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Aquaculture Feed Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Aquaculture Feed Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Aquaculture Feed Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Livestock Feed Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Livestock Feed Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Livestock Feed Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pet Food Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pet Food Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pet Food Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Dietary Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Dietary Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Dietary Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Adult Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Adult Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Adult Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Elderly Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Elderly Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Elderly Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Infant Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Infant Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Infant Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Functional Foods Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Functional Foods Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Functional Foods Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Beverages Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Beverages Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Beverages Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Dairy Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Dairy Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Dairy Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Snack Bars Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Snack Bars Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Snack Bars Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Infant Formula Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Infant Formula Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Infant Formula Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Cow Milk-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Cow Milk-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Cow Milk-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Hypoallergenic Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Hypoallergenic Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Hypoallergenic Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Soy-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Soy-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Soy-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Pharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Pharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Pharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Adjunctive Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Adjunctive Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Adjunctive Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Probiotic Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Probiotic Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Probiotic Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 62. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Enteric-Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Enteric-Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Enteric-Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Non-Enteric Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Non-Enteric Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Non-Enteric Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Global Adults Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Adults Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Adults Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Children Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Children Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Children Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Elderly Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Elderly Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Elderly Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Infants Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Infants Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Infants Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 94. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 115. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 116. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 117. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 118. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 119. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 120. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 121. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 126. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 127. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 128. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 129. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 130. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 131. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 132. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Latin America Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 137. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 138. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 139. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 140. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 141. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 142. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 143. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 148. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 149. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 150. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 151. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 152. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 153. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 154. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Middle East Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 159. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 160. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 161. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 162. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 163. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 164. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 165. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Africa Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 171. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 172. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 173. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 174. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 175. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 176. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 177. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. ASEAN Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 182. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 183. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 184. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 185. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 186. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 187. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 188. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. GCC Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 193. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 194. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 195. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 196. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 197. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 198. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 199. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. European Union Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 204. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 205. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 206. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 207. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 208. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 209. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 210. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. BRICS Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 215. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 216. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 217. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 218. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 219. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 220. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 221. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. G7 Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 226. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 227. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 228. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 229. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 230. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 231. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 232. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. NATO Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Country, 2017-2032 (USD Million)
TABLE 235. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, 2017-2032 (USD Million)
TABLE 236. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 238. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 239. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 240. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 241. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 242. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 243. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 244. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. United States Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, 2017-2032 (USD Million)
TABLE 247. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 249. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 250. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 251. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 252. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 253. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 254. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 255. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Canada Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 257. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, 2017-2032 (USD Million)
TABLE 258. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 260. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 261. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 262. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 263. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 264. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 265. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 266. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Mexico Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, 2017-2032 (USD Million)
TABLE 269. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 271. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 272. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 273. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 274. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 275. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 276. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 277. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Brazil Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 279. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, 2017-2032 (USD Million)
TABLE 280. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 282. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 283. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 284. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 285. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 286. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 287. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 288. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. United Kingdom Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 290. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, 2017-2032 (USD Million)
TABLE 291. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 293. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 294. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 295. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 296. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 297. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 298. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 299. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. Germany Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 301. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, 2017-2032 (USD Million)
TABLE 302. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Application, 2017-2032 (USD Million)
TABLE 303. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Animal Feed, 2017-2032 (USD Million)
TABLE 304. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Dietary Supplements, 2017-2032 (USD Million)
TABLE 305. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Functional Foods, 2017-2032 (USD Million)
TABLE 306. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Infant Formula, 2017-2032 (USD Million)
TABLE 307. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 308. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Form, 2017-2032 (USD Million)
TABLE 309. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Capsule, 2017-2032 (USD Million)
TABLE 310. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. France Bifidobacterium Longum Subsp. Infantis M-63 Market Size, by Distribution Channel, 2017-2032 (USD

Companies Mentioned

  • BioGaia AB
  • Chr. Hansen A/S
  • Danone S.A.
  • DuPont de Nemours, Inc.
  • Evolve Biosystems
  • Fengchen Group Co., Ltd.
  • Fido Pharma Pvt. Ltd.
  • Kerry Group plc
  • Lallemand Inc.
  • Mead Johnson Nutrition
  • Molkem
  • Morinaga Milk Industry Co., Ltd.
  • Nestlé S.A.
  • Probi AB
  • Yakult Honsha Co., Ltd.

Related Topics

Related Reports

Bifidobacterium Longum Lysate (CAS 96507-89-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Bifidobacterium Longum Lysate (CAS 96507-89-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Probiotic Dietary Supplement - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Probiotic Dietary Supplement - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 140 Pages
  • Global
From
Asia-Pacific Digestive Health Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Asia-Pacific Digestive Health Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Asia Pacific
From
Bifidobacterium - Global Strategic Business Report - Product Image

Bifidobacterium - Global Strategic Business Report

  • Report
  • 293 Pages
  • Global
From
Bifidobacterium Infantis Market - Global Forecast 2026-2032 - Product Image

Bifidobacterium Infantis Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.